CD8A and neoplasm: A majority of studies that aim to classify the subset of TILs in the tumor microenvironment use IHC markers for surface proteins, such as CD20 and CD79a for B cells, CD3 for T cells, CD4 and CD8 for T cells, and FOXP3 for regulatory T cells (91, 92).